BRIEF-MDXhealth signs co-marketing agreement with Long Island pathology

April 2 Wed Apr 2, 2014 2:22am EDT

Related Topics

April 2 (Reuters) - Mdxhealth Sa

* Has entered into a co-marketing agreement with LI path (long island pathology, inc.) to promote MDXhealth's confirmmdx for prostate cancer test

* Agreement expands MDXhealth's access to urologists in the highly populated new york and new jersey region

* LI path is a high-end, full-service independent anatomic and clinical pathology laboratory that serves the New York City metropolitan area Source text for Eikon: Further company coverage: